Thrivent Financial for Lutherans’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-98,644
| Closed | -$5.18M | – | 2524 |
|
|
2020
Q3 | $5.18M | Sell |
98,644
-9,761
| -9% | -$404K | 0.01% | 785 |
|
|
2020
Q2 | $3.61M | Buy |
108,405
+3,368
| +3% | +$107K | 0.01% | 810 |
|
|
2020
Q1 | $2.86M | Buy |
105,037
+14,629
| +16% | +$407K | 0.01% | 812 |
|
|
2019
Q4 | $1.78M | Buy |
90,408
+11,980
| +15% | +$192K | 0.01% | 1119 |
|
|
2019
Q3 | $1.02M | Buy |
78,428
+1,146
| +1% | +$13.8K | ﹤0.01% | 1399 |
|
|
2019
Q2 | $962K | Buy |
77,282
+3,930
| +5% | +$52.2K | ﹤0.01% | 1436 |
|
|
2019
Q1 | $1.07M | Buy |
73,352
+5,563
| +8% | +$71.1K | ﹤0.01% | 1321 |
|
|
2018
Q4 | $748K | Buy |
67,789
+13,490
| +25% | +$188K | ﹤0.01% | 1340 |
|
|
2018
Q3 | $1.43M | Buy |
54,299
+1,073
| +2% | +$29K | ﹤0.01% | 1066 |
|
|
2018
Q2 | $1.09M | Buy |
53,226
+1,530
| +3% | +$32.8K | ﹤0.01% | 1202 |
|
|
2018
Q1 | $938K | Buy |
51,696
+4,240
| +9% | +$70.7K | ﹤0.01% | 1273 |
|
|
2017
Q4 | $662K | Buy |
47,456
+936
| +2% | +$12.7K | ﹤0.01% | 1505 |
|
|
2017
Q3 | $861K | Buy |
46,520
+5,980
| +15% | +$100K | ﹤0.01% | 1256 |
|
|
2017
Q2 | $685K | Buy |
40,540
+3,920
| +11% | +$59.7K | ﹤0.01% | 1333 |
|
|
2017
Q1 | $489K | Buy |
36,620
+2,300
| +7% | +$36K | ﹤0.01% | 1546 |
|
|
2016
Q4 | $517K | Buy |
34,320
+2,500
| +8% | +$33K | ﹤0.01% | 1490 |
|
|
2016
Q3 | $372K | Buy |
31,820
+1,460
| +5% | +$17.2K | ﹤0.01% | 1614 |
|
|
2016
Q2 | $328K | Buy |
30,360
+2,490
| +9% | +$25.7K | ﹤0.01% | 1626 |
|
|
2016
Q1 | $258K | Buy |
27,870
+940
| +3% | +$10.1K | ﹤0.01% | 1678 |
|
|
2015
Q4 | $400K | Buy |
26,930
+650
| +2% | +$10.9K | ﹤0.01% | 1450 |
|
|
2015
Q3 | $431K | Buy |
26,280
+3,150
| +14% | +$64.5K | ﹤0.01% | 1274 |
|
|
2015
Q2 | $528K | Buy |
23,130
+5,330
| +30% | +$106K | ﹤0.01% | 1086 |
|
|
2015
Q1 | $271K | Buy |
17,800
+700
| +4% | +$9.1K | ﹤0.01% | 1435 |
|
|
2014
Q4 | $206K | Buy |
17,100
+150
| +0.9% | +$1.71K | ﹤0.01% | 1594 |
|
|
2014
Q3 | $192K | Sell |
16,950
-100
| -0.6% | -$1.14K | ﹤0.01% | 1610 |
|
|
2014
Q2 | $206K | Buy |
17,050
+250
| +1% | +$2.95K | ﹤0.01% | 1621 |
|
|
2014
Q1 | $196K | Hold |
16,800
| – | – | ﹤0.01% | 1485 |
|
|
2013
Q4 | $297K | Buy |
16,800
+100
| +0.6% | +$1.68K | ﹤0.01% | 1276 |
|
|
2013
Q3 | $240K | Hold |
16,700
| – | – | ﹤0.01% | 1352 |
|
|
2013
Q2 | $252 | Buy |
+16,700
| New | +$220K | ﹤0.01% | 1314 |
|
Thrivent Financial for Lutherans's MNTA Position: Q4 2020 in Review
Thrivent Financial for Lutherans sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 98,644 shares — an estimated $5.18M sold.
Thrivent Financial for Lutherans first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $5.18M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Thrivent Financial for Lutherans reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 98,644 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $5.18M.
- Thrivent Financial for Lutherans first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Thrivent Financial for Lutherans's Momenta Pharmaceuticals, Inc. position peaked at $5.18M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Thrivent Financial for Lutherans's 13F filing for Q4 2020, filed 16 Feb 2021.